Cationic lipid-assisted nanoparticles for simultaneous delivery of CD47 siRNA and R848 to promote antitumor immune responses

Introduction: Triple-negative breast cancer (TNBC) usually has a poor prognosis. Although the immunotherapy of TNBC has achieved great progress, only a few patients can benefit from the current treatment. CD47 is widely expressed on the surface of TNBC cells and may become an immune checkpoint for T...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Simin, Chen, Yichang, Ma, Ruolin, Du, Ye, Han, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102467/
https://www.ncbi.nlm.nih.gov/pubmed/37063284
http://dx.doi.org/10.3389/fphar.2023.1142374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102467/
https://www.ncbi.nlm.nih.gov/pubmed/37063284
http://dx.doi.org/10.3389/fphar.2023.1142374

Ejemplares similares